Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001178913-23-003313
Filing Date
2023-10-12
Accepted
2023-10-12 16:05:20
Documents
1
Effectiveness Date
2023-10-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13817
  Complete submission text file 0001178913-23-003313.txt   14880
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: D | Act: 33 | File No.: 021-494608 | Film No.: 231322771
SIC: 2834 Pharmaceutical Preparations